Finance

Lists
Why is OCEA up 200,00%?
Dive Deeper
OCEA:OTCMKTS
Ocean Biomedical Inc
0,00060 $
+200,00%
(+0,00040) 1D
16 հոկ, 09:30:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCEA...
Open
0,00 $
High
0,00 $
Low
0,00 $
Mkt. cap
96,20 հզր
Avg. vol.
51,94 հզր
Volume
102,00
52-wk high
0,01 $
52-wk low
0,00 $
Beta
2,65
Shares outstanding
232,36 մլն
No. of employees
7
Open
0,00 $
High
0,00 $
Low
0,00 $
Mkt. cap
96,20 հզր
Avg. vol.
51,94 հզր
Volume
102,00
52-wk high
0,01 $
52-wk low
0,00 $
Beta
2,65
Shares outstanding
232,36 մլն
No. of employees
7
News stories
From web sources and news partners
Profile
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
About Ocean Biomedical Inc
CEO-
Employees7
Founded2019
Headquarters-
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2024 թ. հնս
2024 թ. սեպ
2024 թ. դեկ
2025 թ. մրտ
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
18,00 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
768,00 հզր
1,75 մլն
940,00 հզր
Operating expense
-
768,00 հզր
1,75 մլն
958,00 հզր
Total operating expenses
-
768,00 հզր
1,75 մլն
958,00 հզր
Operating income
-
-768,00 հզր
-1,75 մլն
-958,00 հզր
Other non operating income
-
-3,82 մլն
2,47 մլն
-6,94 մլն
EBT including unusual items
-
-5,53 մլն
283,00 հզր
-8,24 մլն
EBT excluding unusual items
-
-5,53 մլն
283,00 հզր
-8,24 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-5,53 մլն
283,00 հզր
-8,24 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-461,00 հզր
-433,00 հզր
-343,00 հզր
Net interest expenses
-
-461,00 հզր
-433,00 հզր
-343,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps